Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, 20993, USA.
Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, 20993, USA.
Virology. 2019 Oct;536:125-133. doi: 10.1016/j.virol.2019.08.001. Epub 2019 Aug 2.
The Sf9 cell line is broadly used for manufacturing baculovirus-expressed viral vaccines. We previously reported the presence of a novel, rhabdovirus in the Sf9 cell line, which contained a unique X gene (Sf-rhabdovirus; designated as X in this paper). These results were extended by other reports describing an Sf-rhabdovirus variant in Sf9 cells, which lacked 320 nucleotides encompassing the X-gene and adjacent intergenic region (designated as X in this paper), and the development of an Sf-rhabdovirus negative cell line. Here, we report that the Sf9 cell line is a mixed-cell population, based upon isolation of cell clones with distinct phenotypes: Sf-rhabdovirus-negative, X, and X. We also show that Sf-rhabdovirus X and X variants replicate independently in Sf-rhabdovirus-negative cells. These results shed light on the detection of different rhabdovirus variants by different laboratories using Sf9-derived cell clones and confirm that both X and X viruses are infectious in rhabdovirus-negative Sf9 cells.
Sf9 细胞系被广泛用于生产杆状病毒表达的病毒疫苗。我们之前曾报道 Sf9 细胞系中存在一种新型的弹状病毒,该病毒含有一个独特的 X 基因(在本文中称为 Sf-rhabdovirus;Sf-rhabdovirus;在本文中称为 X)。其他报道进一步扩展了这些结果,描述了 Sf9 细胞中 Sf-rhabdovirus 的变体,该变体缺失了包含 X 基因和相邻内含子区域的 320 个核苷酸(在本文中称为 X),并开发了 Sf-rhabdovirus 阴性细胞系。在这里,我们报告 Sf9 细胞系是一种混合细胞群体,基于分离具有不同表型的细胞克隆: Sf-rhabdovirus 阴性、X 和 X。我们还表明 Sf-rhabdovirus X 和 X 变体可在 Sf-rhabdovirus 阴性细胞中独立复制。这些结果阐明了不同实验室使用 Sf9 衍生的细胞克隆检测不同的弹状病毒变体的情况,并证实 X 和 X 病毒在 Sf9 细胞中均具有感染性。